Young Hoon Jung, Yun Ji Lee, Tam Dao, Kyung Hee Jung, Junjie Yu, Ah-Reum Oh, Yelin Jeong, HyunJoon Gi, Young Un Kim, Dongryeol Ryu, Michele Carrer, Utpal B. Pajvani, Sang Bae Lee, Soon-Sun Hong, KyeongJin Kim
Clin Mol Hepatol 2024;30(4):895-913. Published online August 5, 2024
Background/Aims Potassium channel tetramerization domain containing 17 (KCTD17) protein, an adaptor for the cullin3 (Cul3) ubiquitin ligase complex, has been implicated in various human diseases; however, its role in hepatocellular carcinoma (HCC) remains elusive. Here, we aimed to elucidate the clinical features of KCTD17, and investigate the mechanisms by which KCTD17 affects HCC progression.
Methods We analyzed transcriptomic data from patients with HCC. Hepatocyte-specific KCTD17 deficient mice were treated with diethylnitrosamine (DEN) to assess its effect on HCC progression. Additionally, we tested KCTD17-directed antisense oligonucleotides for their therapeutic potential in vivo.
Results Our investigation revealed the upregulation of KCTD17 expression in both tumors from patients with HCC and mouse models of HCC, in comparison to non-tumor controls. We identified the leucine zipper-like transcriptional regulator 1 (Lztr1) protein, a previously identified Ras destabilizer, as a substrate for KCTD17-Cul3 complex. KCTD17-mediated Lztr1 degradation led to Ras stabilization, resulting in increased proliferation, migration, and wound healing in liver cancer cells. Hepatocyte-specific KCTD17 deficient mice or liver cancer xenograft models were less susceptible to carcinogenesis or tumor growth. Similarly, treatment with KCTD17-directed antisense oligonucleotides (ASO) in a mouse model of HCC markedly lowered tumor volume as well as Ras protein levels, compared to those in control ASO-treated mice.
Conclusions KCTD17 induces the stabilization of Ras and downstream signaling pathways and HCC progression and may represent a novel therapeutic target for HCC.
Citations
Citations to this article as recorded by
Metabolic dysfunction-associated steatotic liver disease and steatohepatitis-associated hepatocarcinoma preclinical models Jack Leslie, Kishore A. Krishnamurthy, Indresh K. Gopalsamy, Patricia Inacio, Meritxell Huch, Suchira Gallage, Fiona Oakley, Michele Vacca Nature Reviews Gastroenterology & Hepatology.2026;[Epub] CrossRef
Correspondence to editorial on “KCTD17-mediated Ras stabilization promotes hepatocellular carcinoma progression” Sang Bae Lee, KyeongJin Kim Clinical and Molecular Hepatology.2025; 31(1): e78. CrossRef
Identification of KCTD17 as a Ras stabilizer in hepatocellular carcinoma: Editorial on “KCTD17-mediated Ras stabilization promotes hepatocellular carcinoma progression” Rainbow Wing Hei Leung, Terence Kin Wah Lee Clinical and Molecular Hepatology.2025; 31(1): 304. CrossRef
The ubiquitin code of RAS proteins: Decoding its role in cancer progression Yedan Shi, Yong Shen, Xiuyuan Zhang, Ning Zhu, Yuwei Ding, Ying Yuan, Juan Wang iScience.2025; 28(8): 113029. CrossRef
Structure, Function, and Role of KCTD9 in Human Diseases 宗军 刘 Journal of Clinical Personalized Medicine.2025; 04(04): 33. CrossRef
Hepatocyte KCTD17-mediated SERPINA3 inhibition determines liver fibrosis in metabolic dysfunction-associated steatohepatitis Yelin Jeong, Ah-Reum Oh, Young Hoon Jung, Kyung Hee Jung, Seongju Lee, Michele Carrer, Sang Bae Lee, Luca Valenti, Utpal B. Pajvani, KyeongJin Kim Experimental & Molecular Medicine.2025; 57(8): 1673. CrossRef
Value of CD8+ T cell-related genes and IL-6/STAT3 signaling pathway in the prognosis of HCC and experimental investigation Yuan Wu, Xiaoli Liu, Lihua Yu, Huiwen Yan, Yuqing Xie, Qing Pu, Yuling Liang, Yaxian Kong, Zhiyun Yang International Journal of Biological Macromolecules.2025; 332: 148526. CrossRef
Wild-type KRAS activation drives evasion of interferon-mediated immunity and resistance to immunotherapy in hepatocellular carcinoma Martina Mang Leng Lei, Carmen Oi Ning Leung, Rainbow Wing Hei Leung, Xue Qian Wu, Katherine Po Sin Chung, Catherine Yu Jia Gu, Mandy Sze Man Chan, Wing Ki Chau, Quan Hua Mu, Kai Yu Ng, Man Tong, Jing Ping Yun, Jia Ming Nickolas Teo, Guang Sheng Ling, Patr Nature Communications.2025;[Epub] CrossRef
First
Prev
